Recombinant multi-species BRD4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BRD4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. This gene has been implicated as the chromosome 19 target of translocation t(15;19)(q13;p13.1), which defines an upper respiratory tract carcinoma in young people. Two alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
The Alternative Names of target: BRD4,Brd4,Brd5,Bromodomain-containing protein 4,CAP,CDLS6,FSHRG4,HUNK1,HUNKI,MCAP,Protein HUNK1,WI-11513
Go
to BRD4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T40556-Ag-1/ GM-Tg-hg-T40556-Ag-2 | Human BRD4 protein | Human |
| GM-Tg-rg-T40556-Ag-1/ GM-Tg-rg-T40556-Ag-2 | Rat BRD4 protein | Rat |
| GM-Tg-mg-T40556-Ag-1/ GM-Tg-mg-T40556-Ag-2 | Mouse BRD4 protein | Mouse |
| GM-Tg-cynog-T40556-Ag-1/ GM-Tg-cynog-T40556-Ag-2 | Cynomolgus/Rhesus macaque BRD4 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T40556-Ag-1/ GM-Tg-felg-T40556-Ag-2 | Feline BRD4 protein | Feline |
| GM-Tg-cang-T40556-Ag-1/ GM-Tg-cang-T40556-Ag-2 | Canine BRD4 protein | Canine |
| GM-Tg-bovg-T40556-Ag-1/ GM-Tg-bovg-T40556-Ag-2 | Bovine BRD4 protein | Bovine |
| GM-Tg-equg-T40556-Ag-1/ GM-Tg-equg-T40556-Ag-2 | Equine BRD4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T40556-Ag-1/ GM-Tg-hg-T40556-Ag-2;
GM-Tg-rg-T40556-Ag-1/ GM-Tg-rg-T40556-Ag-2;
GM-Tg-mg-T40556-Ag-1/ GM-Tg-mg-T40556-Ag-2; GM-Tg-cynog-T40556-Ag-1/ GM-Tg-cynog-T40556-Ag-2; GM-Tg-felg-T40556-Ag-1/ GM-Tg-felg-T40556-Ag-2; GM-Tg-cang-T40556-Ag-1/ GM-Tg-cang-T40556-Ag-2; GM-Tg-bovg-T40556-Ag-1/ GM-Tg-bovg-T40556-Ag-2; GM-Tg-equg-T40556-Ag-1/ GM-Tg-equg-T40556-Ag-2 |
| Products Name | BRD4 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | BRD4 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BRD4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.